Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05675618 · ClinicalTrials.gov registry record
Return to Golf After Orthopaedic Surgery
A clinical trial of Knee Osteoarthritis and Hip Osteoarthritis, sponsored by Hospital for Special Surgery, New York.
- Recruiting
- Registry status
- 432
- Enrollment target
- 2
- Study locations
NCT05675618: Recruiting study of Knee Osteoarthritis and Hip Osteoarthritis, sponsored by Hospital for Special Surgery, New York.
NCT05675618 is a study of Knee Osteoarthritis and Hip Osteoarthritis that is actively recruiting participants, run by Hospital for Special Surgery, New York. The registered enrollment target is 432 participants, above the 300-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (44% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05675618, a study of Knee Osteoarthritis and Hip Osteoarthritis, is actively recruiting participants, sponsored by Hospital for Special Surgery, New York.
- RECRUITING
- Registry status
- 432 participants
- Enrollment target
- 2
- Study locations
Study Summary
The GOLF study is a multicenter, prospective study with the goal to investigate golfers' return to the sport following hip, knee or shoulder arthroplasty. The prevalence of return to golf, by level of returning to golf will be assessed at 6 weeks, 3 months, 6 months, and 12 months postoperatively. Patients who are active golfers undergoing joint replacement will be identified from outpatient clinics and pre-assessment clinics and given information about the study at least two weeks prior to surgery. Participants in this study must have a desire to return to golf after surgery. Previous studies have only been able to report the return to golf after arthroplasty retrospectively; the prospective nature of this study will allow for a greater understanding of this process.
Primary Outcome
Patients will be asked if they have returned to golf (putting, chipping, 9 holes, 18 holes, etc) following joint arthroplasty.
Conditions Studied
Study Locations (2)
New York
- Hospital for Special Surgery - New York
Other
- Royal Infirmary of Edinburgh - Edinburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 432 participants |
| Start Date | 2023-01-09 |
| Est. Completion | 2026-12 |
What NCT05675618 shows while recruiting
NCT05675618 is an observational study that tracks outcomes without assigning an intervention. The registered 432 participants enrollment target is mid-sized for trials with a published cap, above the 300-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (44% higher).
The record links to 3 conditions, with Knee Osteoarthritis appearing as the primary indexed condition, and to 0 interventions.
NCT05675618 reports a single indexed study location in New York, Other.
Frequently Asked Questions
What is clinical trial NCT05675618 about?
NCT05675618 is a clinical study titled "Return to Golf After Orthopaedic Surgery". The GOLF study is a multicenter, prospective study with the goal to investigate golfers' return to the sport following hip, knee or shoulder arthroplasty. The prevalence of return to golf, by level of returning to golf will be assessed at 6 weeks, 3 months, 6 months, and 12 months postoperatively. P...
What is the current status of trial NCT05675618?
This trial is currently recruiting. The enrollment target is 432 participants. The study started on 2023-01-09. Estimated completion is 2026-12.
What conditions does trial NCT05675618 study?
This clinical trial studies the following conditions: Knee Osteoarthritis, Hip Osteoarthritis, Shoulder Osteoarthritis.
Who is sponsoring clinical trial NCT05675618?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05675618 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Knee Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05675618's enrollment target sits among peer trials
432 11th of 101 higher than 91 of 101 other Knee Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Knee Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Changes in Synovial Fluid Before and After GAE for Knee Osteoarthritis
RECRUITING · NA
-
Focused Extracorporeal Shockwave Therapy for Knee Arthritis
RECRUITING · NA
-
A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression
RECRUITING · Early Phase 1
-
Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis
RECRUITING · Phase 4
-
Creation of a Prospective Data Collecting Registry for Genicular Artery Embolization for Arthritis
RECRUITING
-
Mechanical Alignment Vs Kalipered Kinematic Alignment Total Knee Arthroplasty
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05271240 · 432 participants · Phase 3
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
- NCT05365815 · 432 participants · NA
Melanated Group Midwifery Care (MGMC)
- NCT05499507 · 432 participants · NA
The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)
- NCT05806164 · 432 participants · Phase 4
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI